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Abstract
Background:  The  presence  of  a  family  history  implies  an  increased  risk  for  developing  colorectal
cancer (CRC),  and  may  require  a  different  screening  strategy.
The  aim  of  this  study  was  to  evaluate  lesions  found  during  colonoscopies  of  patients  that  had
a family  history  of  CRC.
Material  and  methods:  A  retrospective  study  was  conducted  that  included  consecutive  colo-
noscopies  performed  on  patients  with  a  family  history  of  CRC  at  a  referral  center  within  the
period from  April  2000  to  January  2012.  The  colonoscopic  ﬁndings  were  analyzed  in  relation  to
sex, age,  and  the  presence  or  absence  of  symptoms.
Results:  Data  from  3,792  colonoscopies  were  collected.  The  mean  age  of  the  patients  was
53.14 years  (SD  12.22),  and  57.4%  were  women.  Colonoscopy  was  normal  in  71.7%  of  the  cases,
with hyperplastic  polyps  being  detected  in  7.1%,  and  adenomatous  polyps  in  19.8%  (39.4%  of
them were  high  risk).  There  was  a  1.5%  presence  of  adenocarcinomas  in  the  subjects.  Polyps  and
CRC were  predominant  in  men  (P=.001  and  P=.027,  respectively)  and  there  was  a  linear  increase
with age.  Symptomatic  patients  had  a  higher  CRC  detection  rate  (P<.001),  but  no  differences
were observed  in  relation  to  polyp  diagnosis.
 Please cite this article as: Álvarez-Cuenllas B, Díez-Rodríguez R, Vaquero L, Pisabarros C, Aparicio M, Rodríguez-Martín L, et al. Análisis
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Conclusions:  Age  and  male  sex  increased  the  risk  for  presenting  with  CRC  or  adenomas  in  the
group of  patients  with  a  family  history  of  CRC,  and  the  presence  of  symptoms  was  associated
with a  greater  risk  for  presenting  with  CRC.
© 2014  Asociación  Mexicana  de  Gastroenterología.  Published  by  Masson  Doyma  México  S.A.
This is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Análisis  descriptivo  de  los  hallazgos  endoscópicos  en  pacientes  con  antecedentes
familiares  de  cáncer  colorrectal
Resumen
Antecedentes:  La  presencia  de  antecedentes  familiares  implica  un  riesgo  aumentado  de  pre-
sentar colorrectal  (CCR),  lo  que  condiciona  una  estrategia  de  cribado  diferente.
El objetivo  de  este  trabajo  fue  evaluar  las  lesiones  halladas  en  las  colonoscopias  de  pacientes
que se  sometieron  a  esta  exploración  y  que  tuvieron  antecedentes  familiares  para  CCR.
Material y  métodos: Se  realizó  un  estudio  retrospectivo  incluyendo  las  colonoscopias  conse-
cutivas realizadas  en  un  centro  de  referencia  desde  abril  del  2000  hasta  enero  del  2012  en
pacientes  con  antecedentes  familiares  de  CCR.  Los  hallazgos  encontrados  en  la  colonoscopia  se
analizaron  en  función  del  sexo,  la  edad  y  la  presencia  o  ausencia  de  síntomas.
Resultados:  Se  recogieron  datos  de  3,792  colonoscopias.  La  edad  media  ±  desviación  estándar
de los  pacientes  fue  de  53.14  ±  12.22  an˜os,  siendo  el  57,4%  mujeres.  La  colonoscopia  fue  normal
en el  71.7%  de  los  casos,  se  detectaron  pólipos  hiperplásicos  en  el  7.1%  y  pólipos  adenomatosos
en el  19.8%  (39.4%  de  ellos,  de  alto  riesgo).  La  presencia  de  adenocarcinomas  se  evidenció  en  el
1.5% de  los  sujetos.  La  presencia  de  pólipos  y  CCR  predomina  en  varones  (p  =  0.001  y p  =  0.027,
respectivamente)  y  aumentan  de  forma  lineal  con  la  edad.  En  los  pacientes  sintomáticos  hubo
mayor tasa  de  detección  de  CCR  (p  <  0.001),  mientras  que  no  se  observaron  diferencias  para  el
diagnóstico  de  pólipos.
Conclusiones:  En  el  grupo  de  pacientes  con  antecedentes  familiares  de  CCR,  la  edad  y  el  sexo
masculino aumentan  el  riesgo  de  presentar  CCR  o  adenomas.  La  presencia  de  síntomas  se  asocia
a mayor  riesgo  de  presentar  CCR.
© 2014  Asociación  Mexicana  de  Gastroenterología.  Publicado  por  Masson  Doyma  México  S.A.
Este es  un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/
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Introduction
Colorectal  cancer  (CRC)  is  the  third  most  frequent  tumor
in  men  and  the  second  in  women  worldwide.1 Incidence  is
greater  in  men  than  in  women  with  a  ratio  of  1.4:1.  This
tumor  represents  8%  of  the  overall  mortality  due  to  cancer,
making  it  the  4th  most  common  cause  of  death  by  cancer.2
The  Health  Sector  in  León,  Spain,  has  rates  that  are  stan-
dardized  with  those  of  the  worldwide  population,  between
33.7  and  41.6  for  men  and  19.8  and  23  for  women  per
100,000  inhabitants.  In  this  area  of  health,  a  study  by  Mar-
tin  Sanchez  et  al.  reported  an  increase  in  the  incidence
rate  from  the  year  1994  to  2008.3 An  increase  in  CRC  inci-
dence,  prevalence,  and  mortality  in  men  and  their  reduction
in  women  are  expected  in  the  coming  years.4 This  upward
trend  is  also  observed  in  other  regions  of  the  world5 where
similar  genetic  factors  are  presupposed.
The  hereditary  forms  of  CRC  (mainly  colorectal  polyps
and  Lynch  syndrome)  make  up  3%  of  the  total  cases  of  CRC.
It  is  estimated  that  up  to  30%  of  CRC  cases  in  the  Span-
ish  population  have  family  aggregation.6 The  genetic  proﬁle
of  the  familial  forms  are  currently  not  well  established.
The  implicated  alleles  are  more  common  and  have  a  lower
penetration.  Pangenomic  association  studies  have  recently
A
c
Adentiﬁed  how  some  single  nucleotide  polymorphisms  could
e  associated  with  the  excess  of  familial  risk,  enabling  the
lassiﬁcation  of  patients  into  subgroups  according  to  their
isk.7
The  relatives  of  patients  with  CRC  have  an  increased
isk  for  presenting  with  this  type  of  neoplasia,  depend-
ng  on  the  degree  of  the  relation  and  the  age  at  which
he  affected  relative  presents  with  the  tumor.8 A  prospec-
ive  study  by  Ng  et  al.9 was  recently  published  in  which
he  siblings  of  patients  with  CRC  had  a  7.5%  prevalence  of
dvanced  neoplasia,  compared  with  2.9%  in  controls.  Know-
ng  the  risk  for  presenting  with  the  disease  in  relatives  of
RC  patients  implies  a  different  screening  strategy  for  early
esion  detection.10
The  aim  of  our  study  was  to  evaluate  colonoscopy  ﬁndings
n  patients  with  a  family  history  (FH)  of  CRC  and  to  ana-
yze  the  factors  associated  with  the  presence  of  neoplastic
esions.
ethods retrospective  study  was  conducted  in  which  the  colonos-
opies  performed  at  our  center  within  the  time  frame  of
pril  2000  and  January  2012  on  outpatients  with  a  FH  of  CRC
1 B.  Álvarez-Cuenllas  et  al.
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presented  with  rectorrhagia,  4  (14.2%)  with  anemia  or  iron
deﬁciency,  3  (10.7%)  had  altered  bowel  habit,  and  2  (7.1%)
with  general  syndrome.
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ere  reviewed.  Asymptomatic  patients,  as  well  as  patients
hat  in  addition  to  a  FH  also  presented  some  symptom,  were
ncluded  in  the  study.  The  successive  examinations  of  any
iven  patient  were  excluded  from  the  analysis.  There  was
o  active  CRC  screening  program  in  place  in  our  health-
are  sector  during  the  time  frame  of  the  study.  The  patients
ere  referred  from  different  specialized  care  consultations
mainly  gastroenterology,  surgery,  and  internal  medicine)
nd  primary  care  consultations.
The  variables  of  sex  and  age  of  the  patients  were  ana-
yzed  (dividing  them  into  3  groups  for  their  evaluation:  under
0  years  of  age,  between  40  and  60  years  of  age,  and  over
0  years  of  age).  The  patients  were  divided  into  2  groups  for
he  analysis  according  to  the  presence  or  absence  of  sym-
tomatology  together  with  a  FH  of  the  disease.  The  purpose
f  this  division  was  to  distinguish  those  patients  that  came
or  screening  from  those  that  had  symptoms;  the  FH  was  a
omplemetary  datum.
In relation  to  the  pathologic  ﬁndings  we  distinguished  the
ollowing  groups  according  to  the  lesion  grade  found:
.  Patients  with  a  normal  colonoscopy  or  extirpation  of
hyperplastic  polyps.
.  Patients  with  adenomas.  This  group  included  all  types
of  adenomas,  sizes,  and  dyplasia  grades.  Patients  were
considered  to  present  with  high-risk  adenoma  if  they  had
at  least  one  polyp  larger  than  1  cm,  more  than  3  polyps,
regardless  of  their  size,  or  at  least  one  polyp  with  high-
grade  dysplasia.
.  Patients  with  a  histology  of  either  microinvading  adeno-
carcinoma  or  inﬁltrating  adenocarcinoma.
If  a  patient  presented  with  several  concomitant  lesions,
e  or  she  was  classiﬁed  in  the  group  of  the  lesion  with  the
ighest  risk.
This  study  was  approved  by  the  Ethics  Committee  of  our
enter  in  accordance  with  the  guidelines  of  the  1975  Decla-
ation  of  Helsinki.
tatistical  analysis
he  study  variables  were  placed  in  an  appropriately  elab-
rated  database  (Microsoft  Access)  and  analyzed  using  a
tatistical  software  package  (SPSS  v.  11.0  for  MacOS  X).  The
uantitative  variables  were  expressed  as  means  ±  standard
eviation  and  the  categorical  variables  as  counts  (percent-
ge).
The  chi-square  test  was  used  for  comparing  the  categor-
cal  variables  and  the  quantitative  variables  were  analyzed
sing  the  Student’s  t  test.  The  chi-square  test  for  linear
rend  was  employed  to  test  for  linear  trend,  calculating  the
orresponding  odds  ratio  (OR)  of  the  case  when  possible.
tatistical  signiﬁcance  was  set  at  a  p  <  0.05.
esults
he  data  from  4,408  colonoscopies  were  collected;
,792  patients  were  ﬁnally  analyzed  after  excluding  the  suc-
essive  examinations  of  any  given  patient.  Figure  1  shows
he  progression  in  time  of  the  number  of  screening  colo-
oscopies  performed  in  relatives  with  or  without  symptoms.
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pigure  1  Progression  of  the  number  of  colonoscopies  ordered
n patients  with  a  family  history  of  CRC.
inear  growth  has  been  observed  in  the  number  of  colo-
oscopies  ordered  for  this  indication  in  the  last  few  years.
igure  2  shows  the  percentages  of  the  normal  colonosco-
ies  (hyperplastic  polyps  are  included  in  this  group)  and  the
nding  of  adenomatous  polyps  and  tumors  during  this  same
eriod.
The  mean  age  of  the  patients  was  53.14  ±  12.22  years
nd  57.4%  of  the  patients  were  women.  Colonoscopy  was
ncomplete  in  3.11%  (118/3,792)  of  the  cases.  Pathologic
ndings  were  encountered  in  28.3%  of  the  patients  glob-
lly.  Colonoscopy  revealed  the  following  ﬁndings:  normal  in
,717  subjects  (71.7%),  hyperplastic  polyps  in  269  (7.1%),
nd  adenomatous  polyps  in  749  (19.8%).  Of  the  adenomatous
olyps,  295/749  (39.4%  of  all  the  adenomas)  were  high-risk.
denocarcinoma  was  detected  in  57  patients,  representing
.5%  of  the  total.
Table  1  shows  the  ﬁndings  in  relation  to  the  presence
r  absence  of  symptoms.  The  groups  were  not  comparable
n  regard  to  age  and  the  older  patients  were  in  the  symp-
omatic  group.  The  symptomatic  patients  presented  with  a
arger  number  of  tumors  and  there  were  no  differences  in
he  presence  of  polyps  in  the  two  groups.  With  respect  to
he  symptomatic  patients  with  adenocarcinoma,  19  (67.9%)igure  2  Correlation  between  the  endoscopies  performed
nd the  pathology  ﬁndings  throughout  the  study  period,  divided
s follows:  normal  or  with  hyperplastic  polyps,  adenomatous
olyps,  and  colorectal  cancer.
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Table  1  Group  characteristics  and  colonoscopy  ﬁndings  according  to  the  presence  or  absence  of  symptoms.
FH  asymptomatic
n  =  3081
FH  symptomatic
n =  711
p  value
Sex  (female)  1,754  (56.9%)  423  (59.5%)  0.213
Age (mean  ±  SD)  52.8  ±  11.9  54.6  ±  13.55  0.02
<40 years  420  (13.6%)  101  (14.2%)  <  0.001
40-60 years  1,843  (59.8%)  354  (49.8%)
>60 years  818  (26.5%)  256  (36%)
Adenocarcinoma  29/2498  (1.2%)  28/575  (4.9%)  <  0.001
Adenomas 613/3,052  (20.1%) 136  /683  (19.9%)  0.919
High risk  adenomas 238/613  (38.8%) 57/136  (41.9%) 0.505
FH asymptomatic: patients with a family history of the disease but without symptoms; FH symptomatic: patients with a family history
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Table  2  shows  the  pathology  found  according  to  age
group  and  the  presence  or  absence  of  symptoms.  The  <
40  year  age  group  presented  with  6/36  (16.7%)  (OR  =  1)
high-risk  adenomas  from  the  adenoma  total  (asymptomatic
patients  with  FH:  3/32  [9.4%];  symptomatic  patients  with
FH:  3/4  [75%]);  the  40-50  year  age  group  had  153/415
(36.9%)  (OR  =  2.92)  (asymptomatic  patients  with  FH:131/354
[37%];  symptomatic  patients  with  FH:  22/346  [6.4%]),  and
the  age  group  above  60  years  had  136/298  (45.6%)  (OR
=  4.2)  (asymptomatic  patients  with  FH:  104/802  [12.9%];
symptomatic  patients  with  FH:  32/71[45%]).  There  was  a
statistically  signiﬁcant  linear  trend  in  the  patient  total  and
in  the  asymptomatic  patients  with  FH  (p  <  0.001),  but  not
in  the  symptomatic  patients  with  FH  (p  =  0.77).
Table  3  shows  the  endoscopic  ﬁndings  by  sex.  The
pathology  predominated  in  men  in  relation  to  polyps  and
adenocarcinomas,  whereas  statistical  signiﬁcance  was  not
achieved  for  high-grade  polyps.
DiscussionThere  has  been  an  important  increase  in  the  number  of  colo-
noscopies  performed  on  patients  with  a  FH  of  CRC  in  the
t
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Table  2  Findings  according  to  age  distribution  and  the  presence  
Age  group  Adenocarcinoma  
FH  FH+symp  Total  
<  40  years  0/388
(0%)
OR:-
1/97
(1%)
OR:  1
1/485
(0.2%)
OR:  1
40- 60  years  13/1,489
(0.9%)
OR:  -
8/293
(2.7%)
OR:  2.69
21/1761
(1.2%)
OR:  5.77
> 60  years  16/591
(2.7%)
OR:  -
19/185
(10.3%)
OR:10.99
35/776
(4.5%)
OR:  22.86
Linear trend
(p-value)
0.000  0.000  0.000  
FH: patients with a family history of the disease but with no symptoms;
symptoms.ast  few  years.  Our  data  revealed  pathology  in  the  exam-
nations  in  28.3%  of  the  patients,  diagnosing  19.8%  with
denomas  and  1.5%  with  adenocarcinomas.  The  presence  of
oth  lesions  predominated  in  men  and  increased  with  age.
esions  in  asymptomatic  patients  under  40  years  of  age  was
xceptional.
In  spite  of  our  results,  we  must  take  into  account  a  series
f  limitations  in  regard  to  the  methodology  of  the  study.  First
f  all,  it  is  a retrospective  study  that  is  based  on  comput-
rized  data  in  which  it  was  possible  to  omit  the  existence
f  a family  history  of  disease  when  including  symptomatic
atients,  resulting  in  selection  bias.  And  the  fact  that  we
id  not  specify  the  patients’  symptoms  could  also  consitute
uch  bias,  inﬂuencing  the  type  of  lesion  found.
Second,  given  that  a computerized  register  of  the  exam-
nations  prior  to  the  year  2000  was  not  available,  we  do  not
now  how  many  patients  might  have  undergone  previous
xaminations,  or  in  which  interval,  which  could  also  skew
he  results.  Concerning  the  characterization  of  the  index
ases,  the  degree  of  family  relation  to  the  affected  rela-
ive  and  his  or  her  age  were  not  entered  into  the  database,
nvalidating  this  study  for  analyzing  the  risk  conferred  by
inship.
of  symptoms.
Adenomatous  polyps  Normal  colon
FH  FH+symp  Total
32/420
(7.6%)
OR:  1
4/100
(4%)
OR:  1
36/520
(6.9%)
OR:  1
484/521
(92.9%)
OR:  1
354/1476
(24%)
OR:  2.91
61/346
(17.6%)
OR:  5.14
415/2176
(19.1%)
OR:  3.17
1,761/2,197
(80.2%)
OR:  3.24
227/802
(28.3%)
OR:  4.79
71/237
(30%)
OR:  10.27
298/1,039
(28.7%)
OR:  5.41
741/1,074
(69%)
OR:  5.88
0.000  0.000  0.000  0.000
 FH + symp: patients with a family history of the disease and with
196  B.  Álvarez-Cuenllas  et  al.
Table  3  Pathology  according  to  sex.
Men  (n  =  1,615)  Women  (n  =  2,177)  p  value
Adenocarcinoma  31  (2.6%)  26  (1.4%)  0.027
Adenomas 417  (26.3%)  332  (15.4%)  0.001
High risk  adenomas  175/417  (42%)  120/332  (36.1%)  0.105
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TThe  risk  for  developing  CRC  in  ﬁrst-degree  relatives  has
een  evaluated  in  numerous  studies  and  meta-analyses  and
s  estimated  to  be  between  2  and  3  times  higher  than  in  the
eneral  population.11 This  risk  increases  the  younger  the  age
f  the  affected  relative,  as  well  as  when  there  are  2  or  more
rst-degree  realtives  diagnosed  with  this  pathology.  Bagli-
tto  et  al.8 reported  that  the  risk  also  appears  to  depend
n  the  kinship;  the  relative  who  has  an  affected  sibling  is
t  greater  risk  (RR:  3.47  95%  CI  [2.24-5.4])  than  when  the
ffected  relative  is  a  parent  (RR:  2.05  95%  CI  [1.63-2.09]).
In  relation  to  the  average-risk  population,  Strul  et  al.12
ound  a  2.6%  prevalence  of  CRC  in  patients  from  76-80  years
f  age,  1.2%  in  patients  from  50  to  75  years  of  age,  and
o  cases  in  patients  from  40  to  49  years  of  age.  CRC  risk
ncreases  not  only  with  age  but  also  when  there  is  a  family
istory  of  CRC;  another  study  reported  a  risk  for  CRC  of  2.5%
n  the  general  population  for  patients  >  75  years  of  age,  4.7%
hen  there  was  a  ﬁrst-degree  relative  with  the  disease,  and
.6%  if  there  were  2  or  more  affected  relatives.13 Our  study
howed  a  0.2%  probability  in  patients  <  40  years,  which  was
qual  to  the  published  data  showing  an  age-related  increase
4.5%  in  patients  >  60  years).
The  prevalence  of  adenomas  in  patients  with  a  ﬁrst-
egree  FH  is  greater  than  that  of  the  general  population  (OR
.7  [95%  CI  1.4-3.5])  and  it  increases  with  age:  at  35  years
OR  0.06  [95%  CI  0.04-0.08]),  at  55  years  (OR  0.19  [95%  CI
.15-0.23]),  and  at  75  years  (OR  0.44  [95%  CI  0.35-0.56]).14
trul  et  al.12 found  a  prevalence  of  advanced  adenoma  of
%  in  patients  from  40-49  years,  of  5.5%  in  patients  from
0-75  years,  and  11.7%  in  patients  from  76  to  80  years,  in
 population  with  no  FH  of  the  disease.  Gupta  et  al.15 ana-
yzed  the  prevalence  of  adenomas  in  ﬁrst-degree  relatives
rom  40  to  49  years  of  age  and  obtained  a  higher  preva-
ence  of  adenomas  in  the  group  with  a  family  history  of  the
athology  (26.7%  vs  13.5%;  p  =  0.002),  with  no  statistical  sig-
iﬁcance  for  advanced  adenomas.  In  our  patient  cohort  only
 patients  under  40  years  of  age  presented  with  advanced
denoma,  making  up  2%  of  the  adenomas  found  in  this  age
roup.  The  number  of  high-risk  adenomas  was  also  observed
o  increase  with  the  age  of  the  patient.
With  respect  to  the  presence  or  absence  of  symptoms,
ur  results  determined  that  symptomatic  patients  had  a
igher  incidence  of  CRC,  with  no  differences  in  relation
o  the  appearance  of  polyps.  A  recent  systematic  review16
oncluded  that  only  bleeding  and  weight  loss  were  associ-
ted  with  the  presence  of  CRC,  albeit  with  a  low  predictive
ower  (AUC  0.66  and  0.67,  respectively).  There  was  no  evi-
ence  that  bowel  habit  alteration,  diarrhea,  constipation,  or
bdominal  pain  were  associated  with  this  neoplasm.  None  of
he  symptoms  analyzed  showed  an  association  with  the  pres-
nce  of  polyps.  In  our  study  the  most  prevalent  symptom  in
he  patients  diagnosed  with  CRC  was  rectorrhagia  (67.9%).
RColorectal  cancer  is  a  prevalent  problem  in  our  society.
nowledge  of  the  prevalence  of  colonic  lesions  that  these
atients  with  a  FH  of  the  disease  present  with  is  necessary
n  order  for  guidelines  to  be  adequately  implemented  in  and
dapted  to  our  environment.17,18 The  number  of  screening
olonoscopies  has  increased  in  our  unit  in  the  last  decade
currently  it  represents  20%  of  the  work  carried  out  there).
dequate  implementation  of  the  CRC  guidelines  is  essential
or  resource  adaptation,  especially  when  17%19 of  colonosco-
ies  performed  for  this  purpose  are  not  properly  indicated,
ccording  to  EPAGE  II  criteria.20
In  conclusion,  age  increases  the  risk  for  presenting  with
RC  or  adenomas  in  patients  with  a FH  of  CRC,  in  both
symptomatic  and  symptomatic  patients,  and  there  is  a
igher  prevalence  in  the  male  sex.  These  ﬁndings  sup-
ort  the  implementation  of  a  screening  program  in  this
igh-risk  population,  adapting  the  resources  and  criteria  in
ccordance  with  current  guidelines.  Despite  the  reports  of
dvances  that  have  been  published,  more  prospective  stud-
es  directed  at  determining  which  relatives  are  at  greater
isk  for  this  disease  are  necessary.
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